WASHINGTON (AP) — U.S. officials on Monday approved the first long-acting drug to protect babies and toddlers against a respiratory virus that sends tens of thousands of American children to the hospital each year.
RSV is a cold-like nuisance for most healthy people, but it can be life-threatening in the very young and the elderly.
The Food and Drug Administration approved the injection for infants and children up to 2 years old who face increased risk of severe RSV.
Rainy Weekend Ahead for the Lakes Region
H2Ozarks Among Groups Benefitting from Latest Grants from Arkansas Department of Agriculture
Traffic Crash in Boone County Kills One, Injures Another
Juneteenth Federal Holiday Closes Government Offices, Financial Institutions
Have Recent Rains Impacted the Drought Levels?